Cargando…
Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series
INTRODUCTION: To report on efficacy, tolerability and safety of rituximab in children with refractory autoimmune diseases. CASE PRESENTATION: Five patients (juvenile dermatomyositis, Wegener's granulomatosis, systemic lupus erythematosus, myasthenia gravis and multiple sclerosis with systemic l...
Autores principales: | Tzaribachev, Nikolay, Koetter, Ina, Kuemmerle-Deschner, Jasmin B, Schedel, Joerg |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827140/ https://www.ncbi.nlm.nih.gov/pubmed/20184679 http://dx.doi.org/10.4076/1757-1626-2-6609 |
Ejemplares similares
-
NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment
por: Kuemmerle-Deschner, Jasmin B, et al.
Publicado: (2011) -
Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021) -
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008) -
Case series: rituximab in the treatment of refractory sight-threatening scleritis
por: van Bilsen, Kiki, et al.
Publicado: (2011) -
A refractory heterogeneous Cryopyrin-Associated Periodic Syndrome (CAPS) phenotype related to V198M mutation responds to canakinumab - a case report
por: Hansmann, Sandra, et al.
Publicado: (2011)